tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
RGLS is currently covered by 4 analysts with an average price target of $116.39. This is a potential upside of $108.23 (1326.35%) from yesterday's end of day stock price of $8.16.
Regulus Therapeutics's activity chart (see below) currently has 41 price targets and 58 ratings on display. The stock rating distribution of RGLS is 57.14% BUY and 42.86% HOLD.
Analysts average stock forecasts to be materialized ratio is 49.18% with an average time for these price targets to be met of 208.54 days.
Highest price target for RGLS is $11, Lowest price target is $7, average price target is $9.
Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 01-May-2025. First documented stock forecast 28-Feb-2014.
Currently out of the existing stock ratings of RGLS, 4 are a BUY (57.14%), 3 are a HOLD (42.86%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 01-May-2025
$9
$0.84 (10.29%)
$6
9 months 22 days ago
(01-May-2025)
1/2 (50%)
$1.15 (14.65%)
34
Hold Since 30-Apr-2025
$11
$2.84 (34.80%)
9 months 24 days ago
(30-Apr-2025)
0/2 (0%)
$3.02 (37.84%)
Hold Since 30-Apr-2025
$7
$-1.16 (-14.22%)
9 months 24 days ago
(30-Apr-2025)
1/2 (50%)
$-0.98 (-12.28%)
370
Buy Since 06-Sep-2019
11 months 9 days ago
(14-Mar-2025)
1/7 (14.29%)
$7.86 (367.29%)
255
Buy Since 05-Jan-2018
$6
$-2.16 (-26.47%)
$240
1 years 11 months 5 days ago
(18-Mar-2024)
1/2 (50%)
$3.64 (154.24%)
408
What is RGLS (Regulus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on RGLS (Regulus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on RGLS (Regulus Therapeutics)?
Which analyst is the currently most bullish on RGLS (Regulus Therapeutics)?
Which analyst is the currently most reserved on RGLS (Regulus Therapeutics)?
